Get the Stockscreener App
33.74
2.35%
-0.89
Sanara Medtech Inc stock is traded at $33.74, with a volume of 8,652.
It is down -2.35% in the last 24 hours and up +39.97% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$34.63
Open:
$33.89
24h Volume:
8,652
Relative Volume:
0.19
Market Cap:
$298.32M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-64.88
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
-0.37%
1M Performance:
+39.97%
6M Performance:
+3.03%
1Y Performance:
-1.93%
1-Day Range:
$33.33
$34.34
1-Week Range:
$33.09
$34.71
52-Week Range:
$23.53
$39.08
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
33.51 | 299.65M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
449.73 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.28 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
78.29 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
|
RMD
Resmed Inc
|
266.27 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
243.57 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech Shares Dip Following CEO Succession Announcement - MSN
Sanara MedTech stock falls after CEO succession announcement - Investing.com
Will breakout in Sanara MedTech Inc. lead to full recovery2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Will Sanara MedTech Inc. stock recover after recent drop2025 Top Decliners & Daily Growth Stock Investment Tips - Newser
Key resistance and support levels for Sanara MedTech Inc.Long Setup & AI Forecasted Entry/Exit Points - Newser
Combining price and volume data for Sanara MedTech Inc.July 2025 Setups & Risk Managed Investment Signals - Newser
Comparing Sanara MedTech Inc. in custom built stock radars2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Has Sanara MedTech Inc. formed a bullish divergence2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Is Sanara MedTech Inc. a candidate for recovery playBreakout Watch & AI Based Buy/Sell Signal Reports - Newser
Is this a good reentry point in Sanara MedTech Inc.Weekly Trade Summary & Verified Momentum Watchlists - Newser
Using portfolio simulators with Sanara MedTech Inc. included2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Sanara MedTech appoints Seth Yon as new CEO effective Sept 15 - Investing.com
Aug Drivers: Is Sanara MedTech Inc. part of any major indexFed Meeting & Verified Momentum Stock Alerts - khodrobank.com
Sanara MedTech Appoints Seth Yon as CEO - MarketScreener
Sanara MedTech Appoints New CEO Ahead of Growth - TipRanks
Seth Yon Named CEO of Sanara MedTech Inc., Ron Nixon to Remain Executive Chairman - Quiver Quantitative
Sanara MedTech Inc. Announces Chief Executive Officer Transition - GlobeNewswire
How institutional ownership impacts Sanara MedTech Inc. stock2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
Detecting price anomalies in Sanara MedTech Inc. with AIRecession Risk & AI Optimized Trade Strategies - Newser
Strategies to average down on Sanara MedTech Inc.July 2025 Macro Moves & Safe Entry Momentum Tips - Newser
What is the earnings history of Sanara MedTech Inc.Rate Cut & Long Hold Capital Preservation Tips - khodrobank.com
Understanding Sanara MedTech Inc.’s price movementQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Is Sanara MedTech Inc. likely to announce a buybackJuly 2025 Levels & Risk Controlled Swing Alerts - khodrobank.com
Does Sanara MedTech Inc. outperform in volatile markets2025 Pullback Review & Verified Chart Pattern Trade Signals - khodrobank.com
Published on: 2025-09-01 10:50:43 - Newser
Analysts Expect Breakeven For Sanara MedTech Inc. (NASDAQ:SMTI) Before Long - Yahoo Finance
Candlestick signals on Sanara MedTech Inc. stock todayWeekly Market Outlook & Low Volatility Stock Recommendations - Newser
Is Sanara MedTech Inc. currently under institutional pressure2025 Earnings Impact & Community Trade Idea Sharing Platform - khodrobank.com
How to interpret RSI for Sanara MedTech Inc. stockEarnings Growth Report & Real-Time Volume Analysis - Newser
Sanara MedTech’s Earnings Call: Growth Amid Challenges - TipRanks
How to read the order book for Sanara MedTech Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-08-31 17:03:40 - Newser
Published on: 2025-08-31 15:21:57 - Newser
Does Sanara MedTech Inc. fit your quant trading modelWeekly Risk Summary & Smart Allocation Stock Reports - Newser
Has Sanara MedTech Inc. found a price floorJuly 2025 Fed Impact & Community Shared Stock Ideas - Newser
Applying chart zones and confluence areas to Sanara MedTech Inc.Insider Buying & Reliable Breakout Forecasts - Newser
Can Sanara MedTech Inc. Escape Recent Bear ChannelPortfolio Growth Summary & Low Drawdown Investment Ideas - beatles.ru
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):